Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 04 Jul 2026 · HPRA open data

SERB S.A. — Licensed Medicines

9 medicines held by SERB S.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 9 products held by SERB S.A.

Medicine	Active substance	Licence holder	Status
Amifampridine SERB 10 mg tablets EU/1/22/1646/001-003	Amifampridine Phosphate	SERB S.A.	—
Amversio 1 g oral powder EU/1/22/1640/001	Betaine anhydrous	SERB S.A.	—
Cyanokit 2.5 g Powder for solution for infusion EU/1/07/420/001	Hydroxocobalamin	SERB S.A.	—
Epistatus 10 mg oromucosal solution PA20595/002/001	Midazolam	SERB S.A.	Not marketed
Epistatus 2.5 mg oromucosal solution PA20595/002/002	Midazolam	SERB S.A.	Not marketed
Epistatus 5 mg oromucosal solution PA20595/002/003	Midazolam	SERB S.A.	Not marketed
Epistatus 7.5 mg oromucosal solution PA20595/002/004	Midazolam	SERB S.A.	Not marketed
FIRDAPSE 10 mg tablets EU/1/09/601/001	3,4-diaminopyridine phosphate	SERB S.A.	—
Fomepizole SERB 5 mg/mL, concentrate for solution for infusion. PA20595/001/001	Fomepizole sulphate	SERB S.A.	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.